Michael O'Dwyer to Pyrimidines
This is a "connection" page, showing publications Michael O'Dwyer has written about Pyrimidines.
Connection Strength
0.356
-
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies. Blood Adv. 2019 06 25; 3(12):1799-1807.
Score: 0.155
-
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med. 2015 Dec 17; 373(25):2425-37.
Score: 0.121
-
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood. 2010 May 06; 115(18):3796-800.
Score: 0.081